Moteur de recherche d’entreprises européennes
Financement de l’UE (4 300 935 €) : Virus Ebola : Approches modernes pour développer des diagnostics rapides au chevet du patient – Sofia réf. : 115843 Hor01/02/2015 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Virus Ebola : Approches modernes pour développer des diagnostics rapides au chevet du patient – Sofia réf. : 115843
The current Ebola Virus Disease (EVD) outbreak has caused more than 5000 deaths within a few months in West Africa (Guinea, Sierra Leone and Liberia being the most severely affected countries), including numerous healthcare workers. It is now is serious public health crisis of international concern . The numbers of cases are still increasing 11 months after the first case was described (December 2013), by mid November 2014 approximately 15000 individuals have been infected and the epidemic is still not under control The direct effects of this outbreak include disruption of standard medical care, insecurity and social disruption in countries that were already struggling to recover from decades of war. One of the most important key actions to limit and stop the spread of this deadly disease is to identify and isolate the EBOV-infected patients. The diagnosis of Ebola Virus infections has in the past, been performed overwhelmingly in specialist reference laboratories with high-performance molecular, serological and culture methods.In recent years many of these functions have been mobilised into rapid response mobile laboratories, indeed several of these units supported by, European, CDC/USA, Canadian, Chinese and African states have been set up to help in the current outbreak by performing laboratory diagnosis, in collaboration with national centres in West Africa. While this type of response has been effective in helping control past EVD outbreaks in rural parts of Africa, it has not been as effective at controlling the current outbreak which is now spreading in densely populated city and slum areas. Unfortunately, the diagnostic procedures currently used in the mobile laboratories are associated with several problems: i) there are a limited number of diagnostic hubs, ii) performing the diagnostic tests correctly requires specialist training, skill and experience, consequently there a limited numbers of trained staff
| AJ INNUSCREEN GmbH | 175 000 € |
| Clonit Srl | 251 250 € |
| 318 125 € | |
| 310 625 € | |
| 200 078 € | |
| 416 666 € | |
| HELSINGIN YLIOPISTO | 146 250 € |
| Inserm Transfert SA | 231 000 € |
| Institut National de la Sante et de la Recherche Medicale | 224 106 € |
| Institut Pasteur | 173 040 € |
| Institut Pasteur DE Dakar | 216 250 € |
| 308 750 € | |
| Kobenhavns Universitet | 312 500 € |
| Statens Serum Institut | 208 375 € |
| Stockholms Universitet | 207 000 € |
| TURUN YLIOPISTO | 115 000 € |
| 279 836 € | |
| Universite d'AIX Marseille | 207 084 € |
https://cordis.europa.eu/project/id/115843
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "AJ INNUSCREEN GmbH - Financement de l’UE (4 300 935 €) : Virus Ebola : Approches modernes pour développer des diagnostics rapides au chevet du patient – Sofia réf. : 115843"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
